Blog

CRISPR Therapeutics Announces Proposed Public Offering of Common Shares – GlobeNewswire (press release)


The Ledger Gazette

CRISPR Therapeutics Announces Proposed Public Offering of Common Shares
GlobeNewswire (press release)
ZUG, Switzerland and CAMBRIDGE, Mass., Jan. 03, 2018 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq:CRSP), a biopharmaceutical company focused on developing transformative gene-based medicines for serious diseases, today announced that it is
Crispr Therapeutics' (CRSP) “Hold” Rating Reaffirmed at CannThe Ledger Gazette


Looking for stock with Analysts Rating? CRISPR Therapeutics AG (CRSP)Wall Street Morning
Unusual Activity Sighted in CRISPR Therapeutics AG (:CRSP) SharesThe Herald

all 7 news articles »

2018-01-03 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.